Pediatric and adolescent COVID-19 vaccination side effects: A retrospective cohort study of the Iranian teenage group in 2021.
COVID-19
adolescent
children
efficacy
pediatric
safety
vaccination
Journal
Journal of medical virology
ISSN: 1096-9071
Titre abrégé: J Med Virol
Pays: United States
ID NLM: 7705876
Informations de publication
Date de publication:
10 2022
10 2022
Historique:
revised:
06
06
2022
received:
20
04
2022
accepted:
24
06
2022
pubmed:
28
6
2022
medline:
19
8
2022
entrez:
27
6
2022
Statut:
ppublish
Résumé
To determine the safety and efficacy profile of teenager COVID-19 vaccination. In this retrospective cohort study, contact numbers of parents of teenagers under 18 years of age referred to a teenager vaccination centers in Tehran-Iran to receive the corona vaccine were collected, and the following information was obtained via the phones: demographic information, type of vaccine, and the number of doses received, as well as additional information like complications and required treatments. Eleven thousand forty-two subjects aged 10-18 years, mean age 14.55 ± 1.83 year including 5374 boys and 5768 girls were investigated. 88.1% received the Sinopharm and 11.9% the Soberana vaccine. General side effects, including fatigue, fever and chills, injection site pain and dizziness, and so forth happened in 2978 cases; 7421 children presented with at least one general or organ-specific side effect following vaccination, including potentially critical side effects, such as vascular injuries, respiratory complication, and so forth. 0.1% of the subject needed hospital admission. The breakthrough infection happened in 200 individuals. Our study shows that Sinopharm and Soberana (PastoCoVac) COVID-19 vaccines are generally safe with no serious side effects in less than 18 years old. COVID-19 infection and reinfection can occur after vaccination, but the incidence is actually tolerable and significantly lower than in the unvaccinated group.
Identifiants
pubmed: 35758760
doi: 10.1002/jmv.27962
pmc: PMC9349687
doi:
Substances chimiques
COVID-19 Vaccines
0
Vaccines
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
4890-4900Informations de copyright
© 2022 Wiley Periodicals LLC.
Références
Med J Islam Repub Iran. 2021 May 17;35:63
pubmed: 34277500
Exp Dermatol. 2021 Sep;30(9):1233-1253
pubmed: 33977531
Eur Rev Med Pharmacol Sci. 2021 Feb;25(3):1663-1669
pubmed: 33629336
Vaccines (Basel). 2021 Sep 29;9(10):
pubmed: 34696210
Pediatr Res. 2021 Dec;90(6):1102-1103
pubmed: 34253861
Molecules. 2020 Dec 23;26(1):
pubmed: 33374759
N Engl J Med. 2021 Feb 18;384(7):589-591
pubmed: 33471977
N Engl J Med. 2021 Oct 14;385(16):1474-1484
pubmed: 34320281
Pediatr Pulmonol. 2020 Oct;55(10):2565-2575
pubmed: 32725955
Arch Med Res. 2022 Jan;53(1):1-8
pubmed: 34311990
N Engl J Med. 2021 Jul 15;385(3):239-250
pubmed: 34043894
J Biosci. 2020;45:
pubmed: 33410425
Age Ageing. 2021 Feb 26;50(2):279-283
pubmed: 33320183
J Biomed Sci. 2020 Dec 20;27(1):104
pubmed: 33341119
Curr Opin Pediatr. 2021 Feb 1;33(1):144-151
pubmed: 33278108
Acta Paediatr. 2020 Jun;109(6):1088-1095
pubmed: 32202343
AAPS J. 2021 Jan 5;23(1):14
pubmed: 33400058
J Cutan Pathol. 2021 Oct;48(10):1266-1276
pubmed: 33978234
J Med Ethics. 2021 Aug;47(8):543-546
pubmed: 34117126
J Med Virol. 2021 Feb;93(2):1057-1069
pubmed: 32761898
Vaccine. 2020 Nov 10;38(48):7668-7673
pubmed: 33071002
Lancet Infect Dis. 2021 Jan;21(1):39-51
pubmed: 33069281
Eur J Cancer. 2021 Sep;154:30-34
pubmed: 34233234
J Med Virol. 2022 Oct;94(10):4890-4900
pubmed: 35758760
Circulation. 2021 Aug 10;144(6):471-484
pubmed: 34281357
BMJ. 2021 Jul 8;374:n1687
pubmed: 34244181
Ann Intern Med. 2021 Feb;174(2):221-228
pubmed: 33090877
Vaccines (Basel). 2021 May 26;9(6):
pubmed: 34073382
Pediatr Allergy Immunol. 2021 Jan;32(1):9-16
pubmed: 33113210
Am J Otolaryngol. 2020 Sep - Oct;41(5):102573
pubmed: 32531620
Heart Lung Circ. 2021 Oct;30(10):1425-1429
pubmed: 34340927
Vaccine. 2021 Jan 22;39(4):667-677
pubmed: 33342635
Arch Dis Child. 2022 Mar;107(3):e1
pubmed: 34732388
Vaccines (Basel). 2021 May 06;9(5):
pubmed: 34066475